This disclosure relates generally to labeling of prescription containers. More particularly, this disclosure relates to methods for labeling prescription containers with labels having color advertising by providing a pre-printed label with color advertising and other color printing by commercially available printing means and subsequently printed with patient and medicine information by the pharmacy using either a laser or thermal printer.
Labels for prescription containers must include certain required information according to Federal and State regulations. This required information typically substantially corresponds to SIG information. SIG is short for Signa (Latin) which means “written,” and this terminology is a remnant from the past when all prescriptions were handwritten and signed by the physician. SIG information refers to the information on the written prescription signed by the physician, which is (1) the name of the patient, (2) identification of the medicine, e.g., the name and strength of the medicine, and (3) brief instructions to the patient for taking the medicine.
In addition, pharmacies generally also include Purpose and Auxiliary information on the label. Purpose information is information that relates to why the medicine is taken—e.g., to reduce inflammation, for nausea, for pain, and the like. Auxiliary information involves information such as food interaction cautions, such as “Do Not Take With Dairy” in the case of tetracycline prescriptions, since tetracycline is made less effective when consumed with dairy.
SIG, Purpose, and Auxiliary information is information that is printed at the pharmacy at the time a prescription container is filled with specific prescription medicine for a specific patient. Currently, for economic and reliability reasons, pharmacies typically print prescription labels in black printing using either laser printers or direct thermal printers. While such printers are reliable and cost-effective, they limit the ability of the pharmacy to print any information or graphics in sharp detail; to print in color; or to do either inexpensively.
Accordingly, improvement is desired in the labeling of pharmaceutical containers. What is desired is a way to label pharmaceutical containers that enables bold, sharp, clear and inexpensive color printed information, such as color advertisements, to be included on prescription labels and that is compatible for subsequent printing by laser printers or thermal print heads at the pharmacy.
The disclosure advantageously describes methods for enabling pharmacies to provide pharmaceutical containers with labels having color advertising.
The methods according to the disclosure enable a pharmacy to have pre-printed labels containing desired and custom color advertising and other color printings not achievable using the single color thermal or laser printers used by pharmacies to print labels at the pharmacy. The pharmacy can control the content of the pre-printed labels and selectively utilize the pre-printed labels as they desire with a single color thermal or laser printer to add printing specific to the patient and the prescription medicine.
In one aspect, the disclosure relates to a method for filling a prescription at a pharmacy. The method includes the steps of obtaining a pre-printed label prepared off-site from the pharmacy. The pre-printed label includes a label substrate that is suitable for printing using both laser printers and thermal printers. The pre-printed label has printing applied using a variety of commercially available printing methods, such as flexographic, offset, or direct digital printing, to provide color advertising on the label selected by the pharmacy to advertise goods or services. The prescription is then filled at the pharmacy by selecting a prescription medicine based on the prescription for dispensing in a container to a patient. Before the label is applied to the container, print is applied to the pre-printed label at the pharmacy using one or more of a thermal printer, an inkjet printer or a laser printer to add printing specific to the prescription medicine and the patient.
The methods of the disclosure enable a pharmacy to have pre-printed labels containing desired and custom color advertising and other color printings not achievable using the single color printers used by pharmacies to print labels at the pharmacy. The pharmacy is able to control the content of the pre-printed labels and to utilize the pre-printed labels as they desire with a single color printer to add printing specific to the patient and the prescription medicine.
Further advantages of the disclosure are apparent by reference to the detailed description in conjunction with the figures, wherein elements are not to scale so as to more clearly show the details, wherein like reference numbers indicate like elements throughout the several views, and wherein:
The disclosure relates to methods for filling prescription containers utilizing one-piece pre-printed labels with color advertising and other color printing for pharmaceutical containers as selected by the pharmacy. The pre-printed labels are printed as by an off-site provider using a variety of printing methods, including flexographic, offset, direct digital or other commercially available methods and are configured to be suitable for use on various prescription containers, including conventional round prescription containers. The pre-printed labels are supplied to a pharmaceutical provider, such as a central fill pharmacy or retail store pharmacy. The pharmaceutical provider or pharmacy may select the content and arrangement of the printing on the pre-printed labels. As will be appreciated, actions indicated herein as being taken by the pharmacy will be understood to be actions taken by staff or other persons associated with the pharmacy.
When the prescription is filled at the pharmacy, staff of the pharmacy selects a prescription medicine based on the prescription for dispensing in a container to a patient and prints on the pre-printed label at the pharmacy using a single color thermal printer to add printing specific to the prescription medicine and the patient. It should be noted that color laser printers can also be used at the pharmacy to also add small amounts of supplemental color to the label, but given the higher cost of color laser printers, their much slower print time, and the expensive cost of color printing, the overwhelming majority of printers—laser or thermal—used in pharmacies only print in black. The label is then applied to the container and the prescription medicine is dispensed for use by the patient. The information added by the pharmacy is SIG, Purpose, and Auxiliary information specific to the patients and the medicines that will be supplied in the containers.
With reference to
As seen in
Returning to
In zone B, printing 18 covers the entirety of zone B and is in yellow. Much of printing 18 is subsequently printed over by the pharmacy with the printing 18 serving as highlighting of the printing provided by the pharmacy. Printing 20 and 22 are also highlighted by the printing 18. Printing 20 is in the color red and runs perpendicular to the length direction of the label 10 and provides a legal warning: CAUTION: Federal law prohibits transfer of this drug to any person other than the patient for whom prescribed. Printing 22 states: THE PRODUCT IN THIS CONTAINER APPEARS AS FOLLOWS: Below printing 22 the pharmacy will provide a written description of the appearance of the prescription medicine.
In Zone C, various advertisement printing is provided. In the example of
The pre-printed label 10 as supplied to the pharmaceutical provider is thereafter printed at the pharmacy to provide the label 10′. The label 10′ is provided by printing onto the pre-printed label 10 using a single color thermal printer to add SIG, Purpose, and Auxiliary information specific to the patients and the medicines that will be supplied in a container to which the label 10′ is affixed.
For example, with reference to
In the zone A, the printing 40 provides the prescription number and the printing 42 provides the name of the patient. The printing 40 and 42 overlies the pre-printing 14 and 16, such as yellow highlighting, of the label 10. The printing 44 provides identification of the medicine, e.g., the name and strength of the medicine, such as Prednisone 10 MG TAB/QLTST. Printing 46 is a barcode having information specific to medication name and dose, or other information relating to the medicine or the patient or both. The printing 48 provides the date the prescription is filled. The printing 50 provides instructions to the patient for taking the medicine. The printing 52 provides the purpose or intended use of the prescription medicine, e.g., To reduce inflammation.
In the zone B, the printing 54 provides refill, expiration, and prescribing physician information. The printing 56 provides includes warning or auxiliary information such as “This medicine may lower your ability to fight off infections. Avoid contact with people who have contagious diseases.” Take with food or milk.” “If You Have Diabetes, This Medicine May Change Your Blood Or Urine Sugar. If This Occurs, Call Your Doctor.” “It is very important that you take or use this exactly as directed. Do not skip doses or discontinue unless directed by your doctor.” The printing 58 provides a written description of the appearance of the prescription medicine, such as for Prednisone, “tablet rounded scored white (VH50).”
In accordance with the disclosure, the pre-printed label 10 as detailed above is provided to the pharmacy. The pharmacy then adds printing specific to the patient and the prescription medicine using a laser or thermal printer to provide the label 10′ which is then applied to a prescription container, such as a round container. Typically, multiple ones of the labels 10 are provided in bulk to the pharmacy for feeding through a thermal printer. For example, multiple ones of the labels 10 may be provided on a single sheet.
Each label 10 may be the same or may differ. For example,
In this regard, it will be appreciated that the pharmacy may desire one or a plurality of different advertisements. In the event of different advertisements, the pharmacy may desire to target certain advertisements to certain classes of patients. This targeting may be accomplished manually or by use of a computer to match available advertisements to patients based on criteria such as age, prescription, address, or other criteria. For example, with regard to the advertisement represented by the printing 26 on
As will be appreciated, labeling methods according to the disclosure enable a pharmacy to have pre-printed labels containing desired and custom color advertising and other color printings not achievable using the single color printers used by pharmacies to print labels at the pharmacy, with the pharmacy being able to control the content of the pre-printed labels and to utilize the pre-printed labels as they desire with a single color thermal or laser printer to add printing specific to the patient and the prescription medicine.
The foregoing description of preferred embodiments for this disclosure have been presented for purposes of illustration and description. They are not intended to be exhaustive or to limit the disclosure to the precise form disclosed. Obvious modifications or variations are possible in light of the above teachings. The embodiments are chosen and described in an effort to provide the best illustrations of the principles of the disclosure and its practical application, and to thereby enable one of ordinary skill in the art to utilize the disclosure in various embodiments and with various modifications as are suited to the particular use contemplated. All such modifications and variations are within the scope of the disclosure as determined by the appended claims when interpreted in accordance with the breadth to which they are fairly, legally, and equitably entitled.
This application is a continuation-in-part to co-pending U.S. application Ser. No. 13/347,288 filed Jan. 10, 2012, and entitled “Overflow Panel System for Pharmaceutical Container,” which claimed priority to U.S. Provisional Application Ser. No. 61/508,347 filed Jul. 15, 2011, and entitled “Overflow Panel System for Pharmaceutical Container,” both of which are incorporated by reference herein in their entireties.
Number | Name | Date | Kind |
---|---|---|---|
5329713 | Lundell | Jul 1994 | A |
5342093 | Weemink | Aug 1994 | A |
5958536 | Gelsinger et al. | Sep 1999 | A |
6036231 | Foote et al. | Mar 2000 | A |
6240394 | Uecker et al. | May 2001 | B1 |
6254952 | Fox et al. | Jul 2001 | B1 |
6368688 | Crum et al. | Apr 2002 | B1 |
6715796 | Foote et al. | Apr 2004 | B2 |
7044664 | Papetti | May 2006 | B2 |
7823726 | Miceli et al. | Nov 2010 | B1 |
8181370 | Mlceli et al. | May 2012 | B1 |
20030112466 | Leonardi | Jun 2003 | A1 |
20030193185 | Valley et al. | Oct 2003 | A1 |
20050209915 | Saluccio | Sep 2005 | A1 |
20060163869 | Alder et al. | Jul 2006 | A1 |
20070213213 | Roth et al. | Sep 2007 | A1 |
20080262930 | Miceli et al. | Oct 2008 | A1 |
20100252474 | Miceli et al. | Oct 2010 | A1 |
20120224225 | Banfield et al. | Sep 2012 | A1 |
20130346156 | Ho | Dec 2013 | A1 |
Entry |
---|
Revision Bulletin Dec. 1, 2007, Chapter 671: Containers—Performance Testing, The United States Pharmacopeial Convention Inc, 2007. |
Epson; “Enhancing Pharmacy Labeling with Color to Improve Patient Safety”; White Paper; Apr. 2011. |
Number | Date | Country | |
---|---|---|---|
61508347 | Jul 2011 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 13347288 | Jan 2012 | US |
Child | 13804930 | US |